Sumitomo Mitsui Asset Management Company LTD Has $8.33 Million Position in CME Group Inc. (CME)
Sumitomo Mitsui Asset Management Company LTD boosted its holdings in CME Group Inc. (NASDAQ:CME) by 15.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 61,388 shares of the financial services provider’s stock after acquiring an additional 8,430 shares during the quarter. Sumitomo Mitsui Asset Management Company LTD’s holdings in CME Group were worth $8,329,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also bought and sold shares of CME. Fiduciary Trust Co. acquired a new position in shares of CME Group during the 2nd quarter valued at $105,000. Quadrant Capital Group LLC increased its position in shares of CME Group by 13.6% during the 2nd quarter. Quadrant Capital Group LLC now owns 944 shares of the financial services provider’s stock valued at $111,000 after purchasing an additional 113 shares during the period. San Francisco Sentry Investment Group CA acquired a new position in shares of CME Group during the 2nd quarter valued at $129,000. Whittier Trust Co. increased its position in shares of CME Group by 2.6% during the 2nd quarter. Whittier Trust Co. now owns 1,057 shares of the financial services provider’s stock valued at $133,000 after purchasing an additional 27 shares during the period. Finally, People s United Financial Inc. increased its position in shares of CME Group by 11.5% during the 2nd quarter. People s United Financial Inc. now owns 1,063 shares of the financial services provider’s stock valued at $133,000 after purchasing an additional 110 shares during the period. Hedge funds and other institutional investors own 82.79% of the company’s stock.
WARNING: This piece was first published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are accessing this piece on another site, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this piece can be accessed at https://theolympiareport.com/2017/11/01/sumitomo-mitsui-asset-management-company-ltd-has-8-33-million-position-in-cme-group-inc-cme.html.
In related news, COO Julie Holzrichter sold 11,915 shares of the company’s stock in a transaction on Monday, August 7th. The shares were sold at an average price of $125.67, for a total value of $1,497,358.05. Following the completion of the transaction, the chief operating officer now directly owns 43,657 shares of the company’s stock, valued at approximately $5,486,375.19. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CFO John W. Pietrowicz sold 2,500 shares of the company’s stock in a transaction on Wednesday, October 11th. The stock was sold at an average price of $136.83, for a total transaction of $342,075.00. The disclosure for this sale can be found here. In the last 90 days, insiders sold 27,779 shares of company stock valued at $3,536,355. 0.57% of the stock is owned by corporate insiders.
Several equities analysts have recently issued reports on the company. BidaskClub cut CME Group from a “hold” rating to a “sell” rating in a research report on Friday, July 28th. Zacks Investment Research cut CME Group from a “hold” rating to a “sell” rating in a research report on Tuesday, July 11th. Keefe, Bruyette & Woods reiterated a “hold” rating and set a $127.00 price target on shares of CME Group in a research report on Friday, July 14th. Citigroup Inc. assumed coverage on CME Group in a research report on Wednesday, July 12th. They set a “buy” rating and a $140.00 price target on the stock. Finally, Jefferies Group LLC reiterated a “buy” rating and set a $128.00 price target on shares of CME Group in a research report on Monday, July 10th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and six have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $138.89.
CME Group Inc. (CME) opened at 137.17 on Wednesday. The company has a 50 day moving average price of $135.17 and a 200-day moving average price of $125.48. The firm has a market capitalization of $46.63 billion, a PE ratio of 28.00 and a beta of 0.73. CME Group Inc. has a one year low of $99.58 and a one year high of $138.49.
CME Group (NASDAQ:CME) last issued its earnings results on Thursday, October 26th. The financial services provider reported $1.19 EPS for the quarter, beating the consensus estimate of $1.16 by $0.03. CME Group had a net margin of 40.94% and a return on equity of 7.89%. The company had revenue of $890.80 million during the quarter, compared to analysts’ expectations of $890.22 million. During the same quarter in the previous year, the company posted $1.05 EPS. The business’s revenue for the quarter was up 5.8% compared to the same quarter last year. On average, equities analysts predict that CME Group Inc. will post $4.78 EPS for the current year.
CME Group Company Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.